|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of bone disorders; Pharmaceutical preparations for ... |
|
2024
|
Invention
|
Methods for treating heterotopic ossification. The invention features dosing regimens and pharmac... |
|
2023
|
P/S
|
Pharmaceutical preparations for the treatment of bone disorders, skeletal disorders, muscular dis... |
|
2022
|
P/S
|
Business administration services relating to patient pharmaceutical reimbursement programs; busin... |
|
|
P/S
|
Business administration of patient pharmaceutical reimbursement programs; business services, name... |
|
|
P/S
|
Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossific... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan disease... |
|
|
P/S
|
Pharmaceutical preparations, but not including pharmaceutical preparations for use in oncology. |
|
|
P/S
|
Pharmaceutical preparations for use in the prevention and the treatment of orphan diseases, immun... |
|
|
P/S
|
Pharmaceutical preparations |
|
|
P/S
|
Pharmaceutical preparations. |
|
2019
|
Invention
|
Methods for treating heterotopic ossification.
The invention describes dosing regimens for treat... |
|
2018
|
Invention
|
Methods for treating heterotopic ossification. The invention describes dosing regimens for treati... |
|
2017
|
Invention
|
Methods for treating multiple osteochondroma (mo). The invention features methods for inhibiting ... |
|
2016
|
Invention
|
Antisense oligonucleotides and methods of use thereof.
The invention is directed to antisense ol... |
